Six more things to know about the first quarter results, according to a May 1 news release from the company:
1. Same-facility revenue increased 10.3 percent.
2. The net loss attributable to Surgery Partners was $24.9 million, compared with a net income of $12.2 million for the same period last year.
3. The adjusted EBITDA for the quarter was $90.1 million, 17 percent more than the prior year period.
4. The adjusted EBITDA margin increased 60 basis points to 13.5 percent.
5. Surgery Partners had cash and cash equivalents of $245.5 million, and $545.9 million of borrowing capacity under its revolving credit facility on March 31.
6. The company raised the outlook for 2023 adjusted EBITDA, which is now expected to be more than $430 million.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.